Evidence map›Paper›PMID 42423845›Full record

ArticleJournal of epidemiology and global health2026

Disease Elimination Is Not Eradication: Rethinking "Disease-Free" Certification in Global Health amid the Global Resurgence of Measles, Polio, and Cholera.

Adanze Nge Cynthia

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Adanze Nge CynthiaSankofa Research and Mentorship Hub, Po Box 281, Buea, Cameroon. ngecynthia22@gmail.com.ORCID http://orcid.org/0000-0003-3802-9653

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease elimination, as defined by the World Health Organization (WHO), denotes the sustained reduction of pathogen transmission to zero within a defined geographic area through ongoing public health intervention. In practice, however, certification of elimination status has frequently operated as a terminal designation, reshaping funding and signalling that a problem has been resolved. This perspective argues that such a conception is both scientifically untenable and operationally hazardous. Drawing on three concurrent, well-documented resurgences, measles across the Americas and Europe, circulating vaccine-derived poliovirus (cVDPV) in high-income settings, and accelerating global cholera mortality, this paper identifies three mechanistically distinct but institutionally convergent pathways through which disease control gains erode: immunological erosion driven by unvaccinated birth-cohort accumulation, virological re-emergence via vaccine-derived pathogen variants in under-immunised populations, and structural collapse of water, sanitation, and hygiene (WASH) infrastructure in conflict-affected settings. Across all three, a shared governance failure is evident: post-certification frameworks reward achievement rather than mandate sustained maintenance. Four targeted reforms are proposed, pathway-sensitive post-certification monitoring, quantitative threshold-triggered status reviews, integration of structural resilience metrics, and reform of public-facing elimination communication. Disease elimination is better understood as a condition of managed equilibrium than as a milestone: it is not secured by certification, it is continuously earned.

Indexed as

CholeraDisease EradicationGlobal HealthMeaslesPoliomyelitisHumansCholeraDisease eliminationHealth system resilienceMeaslesPolioPost-certification surveillance

Identifiers

PMID42423845
PMCPMC13624242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.